Healthcare · Biotechnology · NASDAQ
| Market cap | $130.53B |
|---|---|
| Trailing P/E | 27.1 |
| FCF yield | 2.4% |
| Revenue growth (YoY) | +8.9% |
| EPS growth (YoY) | +6248.3% |
| FCF/share growth (YoY) | — |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
Vertex Pharmaceuticals Incorporated trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| David J. Taylor | House | Sell | $1,001 - $15,000 | Sep 5, 2026 |
| Thomas H Tuberville | Senate | Sell | $1,001 - $15,000 | Aug 5, 2026 |
| Thomas H Tuberville | Senate | Sell | $1,001 - $15,000 | Aug 5, 2026 |
| Alan Armstrong | Senate | Buy | $1,001 - $15,000 | Jul 21, 2026 |
| Alan Armstrong | Senate | Buy | $1,001 - $15,000 | Jul 21, 2026 |
| David J. Taylor | House | Sell | $1,001 - $15,000 | Feb 2, 2026 |
| Julia Letlow | House | Buy | $1,001 - $15,000 | Jan 13, 2026 |
| David J. Taylor | House | Buy | $1,001 - $15,000 | Sep 2, 2025 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Aug 13, 2025 |
| Lisa McClain | House | Sell | $1,001 - $15,000 | Aug 13, 2025 |
| Lisa McClain | House | Buy | $1,001 - $15,000 | Aug 13, 2025 |
| Jefferson Shreve | House | Sell | $15,001 - $50,000 | Jun 22, 2025 |